DDInter4 DDInter1016
Synthetic decapeptide antagonist to gonadotropin releasing hormone (GnRH). It is marketed by Praecis Pharmaceuticals as Plenaxis. Praecis announced in June 2006 that it was voluntarily withdrawing the drug from the market.
Lactitol, also known as 4-β-D-galactopyranosyl-D-glucitol, is a sugar alcohol synthesized from [lactose]. It is used in food manufacturing as a nutritive sweetener and is approximately 35% as sweet as table sugar (i.e. [sucrose]). Clinically, lactitol has been investigated for use as an osmotic laxative and, along with other non-absorbable disaccharides such as [lactulose], in the treatment of hepatic encephalopathy in patients with cirrhosis.[A190915,A190918] Pizensy, an oral lactitol powder for solution, was approved by the FDA for use in chronic idiopathic constipation in February 2020.
Abarelix {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Abarelix {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Aripiprazole
Abarelix {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Vasopressin
Abarelix {u} may lead to a major life threatening interaction when taken with {v} Iloperidone
Abarelix may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Abarelix may cause a moderate interaction that could exacerbate diseases when taken with Aripiprazole
Abarelix may cause a moderate interaction that could exacerbate diseases when taken with Vasopressin
Abarelix may lead to a major life threatening interaction when taken with Iloperidone